The Federal Drug Administration announced late last week that a fish-oil-derived medication, Vascepa, had been approved to prevent heart attacks, strokes and death in people who are at high cardiovascular risk. 'The FDA recognizes there is a need for additional medical treatments for cardiovascular
The Federal Drug Administration announced late last week that a fish-oil-derived medication, Vascepa, had been approved to prevent heart attacks, strokes and death in people who are at high cardiovascular risk.
"I believe this is the biggest thing since statins," Dr. Deepak Bhatt, executive director of the Interventional Cardiovascular Program at Brigham and Women’s Hospital Heart and Vascular Center and professor of medicine at Harvard Medical School, told ABC News. He was involved in the long-term study that showed people with high triglycerides who were taking Vascepa had a 25% reduction in the risk of heart attacks, strokes and death compared to the those who received placebo.
Vascepa sets itself apart because medications that reduce triglyceride levels, such as extended-release niacin and fibrates, have not reduced the rates of cardiovascular events in randomized trials when administered in addition to appropriate medical therapy, including statins, according to the New England Journal.
Story continuesMORE: Fish oil And vitamin D pills no guard against cancer or serious heart trouble: Study Patients aren't the only one's hopeful about the drug's benefits. The American Heart Association and the American Diabetes Associations have already updated their treatment guidelines to include Vascepa.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
FDA approves omega-3 fish-oil medication Vascepa to reduce risk of death in people with high cholesterolFDA approves Vascepa, a fish-oil-derived medication that could help prevent heart attacks, strokes and death in people who are at high cardiovascular risk.
Consulte Mais informação »
FDA approves fish-oil drug for cutting cardiac risksIn patient testing, the drug reduced risks of potentially deadly complications including heart attacks and strokes about 25 percent.
Consulte Mais informação »
FDA approves omega-3 fish-oil medication Vascepa to reduce risk of death in people with high cholesterolFDA approves Vascepa, a fish-oil-derived medication that could help prevent heart attacks, strokes and death in people who are at high cardiovascular risk.
Consulte Mais informação »
FDA approves fish-oil drug for cutting cardiac risksIn patient testing, the drug reduced risks of potentially deadly complications including heart attacks and strokes about 25 percent.
Consulte Mais informação »
Oil prices fall but hold near three-month high on trade deal agreementOil prices fell but remained near three-month highs on Monday after the United S...
Consulte Mais informação »